Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
1 other identifier
observational
450
1 country
1
Brief Summary
The purpose of this study is to determine whether progesterone hormone levels differ following egg retrieval with a single lumen needle compared with a double lumen needle. These levels will be measured on several days before and after egg retrieval. The progesterone levels in each IVF group will also be compared to the group of women who are having IUI. In addition, these progesterone levels will be correlated with pregnancy outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 17, 2012
CompletedFirst Posted
Study publicly available on registry
January 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJanuary 20, 2012
January 1, 2012
1 year
January 17, 2012
January 17, 2012
Conditions
Keywords
Study Arms (2)
IVF population
Long Lupron IVF Population
IUI patients
Patients undergoing IUI
Eligibility Criteria
IUI patients and IVF patients following a long lupron protocol cycle
You may qualify if:
- Ages between 21-37
- Cycle Day 3 FSH between 2-12
- History of regular menstrual cycles between 24-34 days
You may not qualify if:
- Previous IVF failure
- Severe male factor
- Severe obesity, BMI \> 40
- More than 20 follicles on ultrasound prior to retrieval
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Red Rock Fertility Centerlead
- Watson Pharmaceuticalscollaborator
Study Sites (1)
Red Rock Fertility Center
Las Vegas, Nevada, 89148, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva D Littman, M.D.
Red Rock Fertility Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2012
First Posted
January 20, 2012
Study Start
January 1, 2012
Primary Completion
January 1, 2013
Study Completion
June 1, 2013
Last Updated
January 20, 2012
Record last verified: 2012-01